Notably, our computational analysis of this high-dimensional data suggests that the key changes correlating with inhibition of tumor growth include the downregulation of CCL-2, CCL-7, CCL-12, and the upregulation of CXCL-10, CCL-24, CXCL-12 and IL-3. The gene discussed is CCL2; the disease is neoplasm.